ClinicalTrials.Veeva

Menu

LIVInG With chrONic Cancer TrEatments (LONGEVITI) Study

U

University of Alberta

Status

Enrolling

Conditions

Breast Cancer
Multiple Myeloma
Melanoma
Chronic Leukemia
Lung Cancer
Cancer
Ovarian Cancer
Prostate Cancer
Tyrosine Kinase Mutation
Colorectal Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT05645510
HREBA.CC-22-0196

Details and patient eligibility

About

People with advanced chronic cancers are now living for many years as a result of new targeted anti-cancer treatments. Many of these treatments are quite new and people may take them for months, even years, as long as the treatments are helping. The purpose of this study is to help understand how to best support people receiving these treatments.

Full description

Participants ill be scheduled for an in-person, telephone or computer video interview with the researcher(s). They will be asked about their experiences receiving targeted anti-cancer treatments. Then over the next 3 months, participants will be asked to think about how receiving these cancer treatments affects daily living and to create a 'metaphor'. Metaphors may be composed with any mix of visual, verbal, musical or other works participants feel expresses and brings their experiences to life.

Enrollment

75 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: taking chronic targeted anti-cancer agents -

Exclusion Criteria:

Trial contacts and locations

1

Loading...

Central trial contact

Edith Pituskin, PhD; Meredith Porter Hogg, MN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems